Control | Non-restrictive | Restrictive | |
E:A ratio | 0.93 (0.29) | 0.92 (0.27) | 1.56 (0.32)2-160 |
DT (ms) | 188 (41) | 196 (44) | 117 (13)2-160 |
IRT (ms) | 82 (20) | 89 (18) | 62 (12)2-160 |
S (cm/s) | 52 (7) | 46 (9) | 39 (11)2-160 |
D (cm/s) | 38 (10) | 37 (9) | 48 (10)2-160 |
R (cm/s) | 21 (3) | 25 (3) | 30 (4)2-160 |
AD-RD (ms) | 29 (20) | 26 (18) | –15 (10)2-160 |
EDVI (ml/m2) | 62 (21) | 73 (18)2-151 | 93 (17)2-160 |
ESVI (ml/m2) | 29 (11) | 37 (13)2-164 | 43 (10)2-160 |
EF (%) | 61 (9) | 51 (8)2-164 | 43 (10)2-160 |
Values are expressed as mean (SD).
2-150 p < 0.05;
↵2-160 p < 0.01 restrictive versus non-restrictive;
↵2-151 p < 0.05,
↵2-164 p < 0.01 non-restrictive versus control.
AD-RD, mitral A wave duration minus pulmonary venous flow reversal duration; D, diastolic pulmonary peak flow velocity; DT, mitral E deceleration time; E:A ratio, early to late peak filling velocity; EDVI, end diastolic volume indexed for body surface; EF, left ventricular ejection fraction; ESVI, end systolic volume indexed for body surface; IRT, isovolumetric relaxation time; R, pulmonary venous flow reversal velocity; S, systolic pulmonary venous flow velocity.